Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

AIM: Digoxin is considered contraindicated in light-chain (AL) amyloidosis, given reports of increased toxicity published 30–50 years ago. We sought to determine the frequency of digoxin toxicity in patients with AL. METHODS: We identified 107 patients with AL amyloidosis who received digoxin betwee...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Amyloid
Main Authors: Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Lin, Grace, Boilson, Barry, Clavell, Alfredo, Lacy, Martha Q., Buadi, Francis K., Hayman, Suzanne R., Kapoor, Prashant, Dingli, David, Rajkumar, S. Vincent, Dispenzieri, Angela, Grogan, Martha
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7433245/
https://ncbi.nlm.nih.gov/pubmed/29529877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13506129.2018.1449744
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados